Association between the BDNF Val66Met Polymorphism and Chronicity of Depression
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective Both clinical and biological factors influence the course of depressive disorders. This study tested for associations between the brain-derived neurotrophic factor (BDNF) gene at the Val66Met locus and the course of major depressive disorder (MDD). Methods Three hundred ten Korean subjects (209 patients, 101 controls) were genotyped for rs6265 at nucleotide 196 (G/A), which produces an amino acid substitution at codon 66 (Val66Met) of the gene for BDNF. Course of illness was evaluated both by chronicity of current episode (episode duration >24 months) and by the lifetime history of recurrences. Results Patients with the Met/Met BDNF genotype had a significantly higher rate of chronic depression than all others. There was a significant dose effect of the Met allele on chronicity. Compared with the Val/Val genotype, the relative risk of chronicity was 1.67 for the Val/Met genotype, and 2.58 for the Met/Met genotype. Lifetime history of recurrent episodes was not related to BDNF genotypes but was significantly associated with younger age of onset and with a history of depression in first degree relatives. Conclusion BDNF genotyping may be informative for anticipating chronicity in major depression.
Abstract
Objective Both clinical and biological factors influence the course of depressive disorders. This study tested for associations between the brain-derived neurotrophic factor (BDNF) gene at the Val66Met locus and the course of major depressive disorder (MDD). Methods Three hundred ten Korean subjects (209 patients, 101 controls) were genotyped for rs6265 at nucleotide 196 (G/A), which produces an amino acid substitution at codon 66 (Val66Met) of the gene for BDNF. Course of illness was evaluated both by chronicity of current episode (episode duration >24 months) and by the lifetime history of recurrences. Results Patients with the Met/Met BDNF genotype had a significantly higher rate of chronic depression than all others. There was a significant dose effect of the Met allele on chronicity. Compared with the Val/Val genotype, the relative risk of chronicity was 1.67 for the Val/Met genotype, and 2.58 for the Met/Met genotype. Lifetime history of recurrent episodes was not related to BDNF genotypes but was significantly associated with younger age of onset and with a history of depression in first degree relatives. Conclusion BDNF genotyping may be informative for anticipating chronicity in major depression.
참고문헌 (25)
- Angst J, "Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985", Schweiz Arch Neurol Psychiatr, 146, pp.17~23 (1995)
- Frodl T, "Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression", Arch Gen Psychiatry, 64, pp.410~416 (2007)
- Duman RS, "A neurotrophic model for stress-related mood disorders", Biol Psychiatry, 59, pp.1116~1127 (2006)
- Egan MF, "The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function", Cell, 112, pp.257~269 (2003)
- Chen ZY, "Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior", Science, 314, pp.140~143 (2006)
- Hwang JP, "The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression", Neurobiol Aging, 27, pp.1834~1837 (2006)
- Nierenberg AA, "Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy", J Clin Psychiatry, 64(Suppl 15), pp.13~17 (2003)
- Quitkin FM, "The importance of dosage in prescribing antidepressants", Br J Psychiatry, 147, pp.593~597 (1985)
- Depression Guideline Panel. Clinical Practice Guideline. Number 5: Depression in Primary Care, Volume 2, "Agency for Health Care Policy and Research", Treatment of Major Depression. U.S. Dept. of Health and Human Services, Public Health Service, ~, pp.AHCPR Publication No. 93-0551 (1993)
- First MB, "Structured Clinical Interview for DSM-IV Axis I Disorders-Clinical Version (SCID-CV)" (1997), American Psychiatric Press
- Kim DK, "Serotonin transporter gene polymorphism and antidepressant response", Neuroreport, 11, pp.215~219 (2000)
- Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiatry, 23, pp.56~62 (1960)
- Colligan RC, "The MMPI: development of contemporary norms", J Clin Psychol, 40, pp.100~107 (1984)
- American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders - Text Revision (DSM-IV TR) (4th ed)" (2000), American Psychiatric Association
- Keller MB, "Implications of failing to achieve successful longterm maintenance treatment of recurrent unipolar major depression", Biol Psychiatry, 44, pp.348~360 (1998)
- Choi MJ, "Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder", Brain Res, 1118, pp.176~182 (2006)
- Pivac N, "Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants", Croat Med J, 50, pp.43~48 (2009)
- Tsai SJ, "Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response", Am J Med Genet B Neuropsychiatr Genet, 123B, pp.19~22 (2003)
- Rush AJ, "The varied clinical presentations of major depressive disorder", J Clin Psychiatry, 68(Suppl 8), pp.4~10 (2007)
- Videbech P, "Hippocampal volume and depression: a meta- analysis of MRI studies", Am J Psychiatry, 161, pp.1957~1966 (2004)
- Jessen F, "No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression", Psychiatr Genet, 19, pp.99~101 (2009)
- Hybels CF, "Partial remission. A common outcome in older adults treated for major depression", Geriatrics, 61, pp.22~26 (2006)
- Wise RA., "Dopamine, learning and motivation", Nat Rev Neurosci, 5, pp.483~494 (2004)
- Shimizu E, "Ethnic difference of the BDNF 196G", A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits, 2004, pp.126B, 122~123
- Hunnerkopf R, "Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits", Neuropsychopharmacology, 32, pp.2552~2560 (2007)